Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients
Authors
Keywords
-
Journal
OncoImmunology
Volume -, Issue -, Pages 1-13
Publisher
Informa UK Limited
Online
2018-08-25
DOI
10.1080/2162402x.2018.1509821
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High ALDH1 expression correlates with better prognosis in tumorigenic malignant melanoma
- (2017) Laura A Taylor et al. MODERN PATHOLOGY
- Programmed cell death 1 checkpoint inhibitors in the treatment of patients with advanced melanoma
- (2017) Jacek Mackiewicz et al. Wspolczesna Onkologia-Contemporary Oncology
- Myeloid regulatory cells in tumor spreading and metastasis
- (2015) Anton A. Keskinov et al. IMMUNOBIOLOGY
- Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma
- (2015) Ines Chevolet et al. Journal of Translational Medicine
- Whole Cell Therapeutic Vaccine Modified With Hyper-IL6 for Combinational Treatment of Nonresected Advanced Melanoma
- (2015) Jacek Mackiewicz et al. MEDICINE
- Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma
- (2015) Lili Yue et al. MELANOMA RESEARCH
- Review Immunotargeting of cancer stem cells
- (2015) Eliza P. Kwiatkowska-Borowczyk et al. Wspolczesna Onkologia-Contemporary Oncology
- Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cells
- (2015) Lin Lu et al. OncoImmunology
- Multiple regulation pathways and pivotal biological functions of STAT3 in cancer
- (2015) Jie Yuan et al. Scientific Reports
- Increased frequencies of CD11b+CD33+CD14+HLA-DRlowmyeloid-derived suppressor cells are an early event in melanoma patients
- (2014) Berenice M. Rudolph et al. EXPERIMENTAL DERMATOLOGY
- Myeloid-derived suppressor cells in malignant melanoma
- (2014) Viktor Umansky et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- RhoC Regulates Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma by Overexpressing IL-6 and Phosphorylation of STAT3
- (2014) Mozaffarul Islam et al. PLoS One
- IL-6 trans-Signaling-Dependent Rapid Development of Cytotoxic CD8+ T Cell Function
- (2014) Jan P. Böttcher et al. Cell Reports
- Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
- (2013) Cristina Iclozan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients
- (2013) Kimberly R. Jordan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients
- (2013) Ang Huang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pancreatic Cancer-Associated Stellate Cells Promote Differentiation of Myeloid-Derived Suppressor Cells in a STAT3-Dependent Manner
- (2013) T. A. Mace et al. CANCER RESEARCH
- Therapeutic gene modified cell based cancer vaccines
- (2013) Anna Kozłowska et al. GENE
- Vemurafenib reverses immunosuppression by myeloid derived suppressor cells
- (2013) Bastian Schilling et al. INTERNATIONAL JOURNAL OF CANCER
- Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma
- (2013) Tamar Kapanadze et al. JOURNAL OF HEPATOLOGY
- Long-term survival of high-risk melanoma patients immunized with a Hyper-IL-6-modified allogeneic whole-cell vaccine after complete resection
- (2012) Andrzej Mackiewicz et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
- (2012) Stefan Rose-John International Journal of Biological Sciences
- ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets
- (2012) Yuchun Luo et al. STEM CELLS
- Optimal Thawing of Cryopreserved Peripheral Blood Mononuclear Cells for Use in High-Throughput Human Immune Monitoring Studies
- (2012) Hari Ramachandran et al. Cells
- A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells
- (2011) S. Solito et al. BLOOD
- Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines
- (2011) I. Poschke et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4+ T cells from patients with GI malignancy
- (2011) Bethany L. Mundy-Bosse et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
- (2011) Paola Filipazzi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
- (2011) Rachel F. Gabitass et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting ALDHbright Human Carcinoma-Initiating Cells with ALDH1A1-Specific CD8+ T Cells
- (2011) C. Visus et al. CLINICAL CANCER RESEARCH
- Function but not phenotype of melanoma peptide-specific CD8+ T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696)
- (2011) Carsten Schaefer et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
- (2011) Tangying Lu et al. JOURNAL OF CLINICAL INVESTIGATION
- CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function
- (2011) Jahyang Choi et al. TUMOR BIOLOGY
- Design of clinical trials for therapeutic cancer vaccines development
- (2009) Jacek Mackiewicz et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration
- (2009) Claudia Drucker et al. JOURNAL OF AUTOIMMUNITY
- IL4Rα + Myeloid-Derived Suppressor Cell Expansion in Cancer Patients
- (2009) Susanna Mandruzzato et al. JOURNAL OF IMMUNOLOGY
- Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells
- (2008) Ilaria Marigo et al. IMMUNOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now